Background The introduction of solid-phase immunoassay (SPI) technology for the detection
and characterization of human leukocyte antigen (HLA) antibodies in transplantation while …

The detection of antibodies against the human leukocyte antigen (HLA) complex has become
indispensable in every clinical practice. The development of solid-phase assays like the …

Macrophages derived from human induced pluripotent stem cells (iPSCs) have the potential
to enable the development of cell-based therapies for numerous disease conditions. We …

Pluripotent stem cells ( PSC s) such as embryonic stem cells or induced pluripotent stem cells
represent a promising cell type to gain novel insights into human biology. Understanding …

… (B) Sera of KTx patients available from day 23 ± 5 after boost immunization were retested
for reactivity as in A with n = 24. (C) Serological reactivity was quantified only in responding …

… After experiencing a shift in rh from 85% to 35%, Col 0 and aba3-1 exhibit a loss of K+;
aba3-1 guard cell K+ content was higher under control and stress conditions than WT (n R 6 6 …

… In this failure group, the incidence of DSA was 21.2% (n=45) compared with 6.0% (n=48) of
… For a smaller number of HLAab negative patients (n=195), we were able to test a second …

Donor-specific HLA antibodies (DSA) have a negative impact on kidney graft survival. Therefore,
we analyzed the occurrence of DSA and antibody-mediated rejection (AMR) in patients …

Bone-marrow transplantation is an effective cell therapy but requires myeloablation, which
increases infection risk and mortality. Recent lineage-tracing studies documenting that …

Objectives To assess the clinical sensitivity of causes of death, concomitant diseases and
postoperative complications including thromboembolic events in ECMO patients. Methods: …